Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study to Investigate the Efficacy and Safety of Recombinant Growth Hormone as Add-on Treatment in Patients With Severe Fibromialgia

NCT00497562 is registered in ClinicalTrials.gov with Centro Medico Teknon as lead sponsor.

NCT NCT00497562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00497562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study to Investigate the Efficacy and Safety of Recombinant Growth Hormone as Add-on Treatment in Patients With Severe Fibromialgia
Lead sponsor
Centro Medico Teknon
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2004
Completion date
November 30, 2005
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia, growth hormone deficiency